Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
Clinical trial NCT05690204 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05690204
- Sponsor
- Shanton Pharma Pte. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-12
- Primary completion
- 2025-01-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.